EQL Pharma AB (publ)

STO-EQL
Nasdaq Stockholm NYSE
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#18772
Country Rank
#242
Market Cap
242.05 M
Price
8.33
Change (%)
1.47%
Volume
16,368

EQL Pharma AB (publ)'s latest marketcap:

242.05 M

As of 06/07/2025, EQL Pharma AB (publ)'s market capitalization has reached $242.05 M. According to our data, EQL Pharma AB (publ) is the 18772th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 242.05 M
Revenue (ttm) 38.55 M
Net Income (ttm) 4.45 M
Shares Out 29.06 M
EPS (ttm) 0.15
Forward PE 37.36
Ex-Dividend Date n/a
Earnings Date 07/28/2025
Market Cap Chart
Data Updated: 06/07/2025

EQL Pharma AB (publ)'s yearly market capitalization.

EQL Pharma AB (publ) has seen its market value grow from kr1.15 B to kr2.35 B since 2020, representing a total increase of 103.27% and an annual compound growth rate (CAGR) of 17.34%.
Date Market Cap Change (%)
06/07/2025 kr2.35 B -0.37%
12/30/2024 kr2.35 B 142.51%
12/29/2023 kr970.72 M 16.78%
12/30/2022 kr831.22 M -26.29%
12/30/2021 kr1.13 B -2.27%
12/30/2020 kr1.15 B

Company Profile

EQL Pharma AB (publ) Overview

EQL Pharma AB (publ) is a pharmaceutical company specializing in the development, marketing, and distribution of generic medicines. The company serves pharmacies and hospitals across Sweden, Denmark, Norway, Finland, and other European regions.

Key Offerings

  • Injection Products: Designed for inpatient care.
  • Outpatient Formulations: Tailored for outpatient treatment needs.

Company Background

Founded in 2006, EQL Pharma AB (publ) is headquartered in Lund, Sweden.

Frequently Asked Questions

  • What is EQL Pharma AB (publ)'s (STO-EQL) current market cap?
    As of 06/07/2025, EQL Pharma AB (publ) (including the parent company, if applicable) has an estimated market capitalization of $242.05 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • EQL Pharma AB (publ) global market capitalization ranking is approximately 18772 as of 06/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.